Plasma levels of IgM against the HPT78–108 unmodified peptide and HNE modified peptide in CAD patients with a stenosis rate >70% were notably lower than HCs (p < 0.0001, p < 0.0001). Here, CD40LG is linked to coronary artery disorder.